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India has enormous burden of birth defects. 800,000 babies are born annually with birth defects, of this 14,000 are born with thalassemia, as per 2013 report on birth defect surveillance 
of Southeast Asian region [1]. Carrier frequencies rate of various 
hemoglobinopathies ranges from 17% to 30% for sickle cell 
disease, 0.3% to 15% for β-thalassemia. HbE is found in eastern 
half of Indian subcontinent with carrier rate of as high as 60%, 
and for milder forms of α-thalassemia, it varies from 15% to 80% 
(tribal population) in north eastern parts of India [2]. The current 
aim is to decrease thalassemia births by 50% with main focus on 
primary prevention in the form of prenatal screening in the first 
trimester of pregnancy [3].
In this issue of Indian journal of Child Health, Kumar et al 
have published a research where they carried out carried out 
secondary prevention study of hemoglobinopathies by doing 
neonatal screening within the 1st week of postnatal life [4]. 
Population screened was from catchment area of West Bengal, 
Jharkhand, Bihar, and Orissa. This belt has high carrier rate of 
β-thalassemia and hemoglobin E. 4000 neonates were screened 
over a period of 1½ year. Isoelectric focusing was used to detect 
hemoglobin variants. This method has an advantage over high-
performance liquid chromatography (HPLC) method due to its 
high resolution; hence, bands are not overlapped, but at the same 
time, it needs expertise and training of handling the machine. 
Isoelectric focusing (IEC) has not only high sensitivity but also 
has high specificity, thus preventing false negativity in double 
heterozygous cases. Whereas, more conventional method, 
HPLC is more user friendly and easy to interpret. It was found 
to have good kappa agreement with IEF as first line screening 
test for hemoglobinopathies in this study. The current study 
did not mention about total eligible neonates for the screening 
test and how many neonates were missed on first screening. 
This could have been the reason behind not reporting the true 
prevalence of hemoglobinopathies in the study population. 
Previous studies from West Bengal have reported 14–29% rate of 
hemoglobinopathies [2].
Hemoglobin variants have a significant prevalence in India 
and population-based prevention programs are needed. Antenatal 
screening can bring reduction in disease load of birth defects 
attributed by hemoglobinopathies, and in case, both parents are 
carrier, they should be screened in each pregnancy irrespective of 
previous conception result [5]. In case, antenatal screening was 
missed then neonatal screening for hemoglobinopathies using 
HPLC or IFC method may be carried out so that anemia and 
related morbidities are decreased [6].
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